NEXIEN BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nexien Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Nexien Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 70.5M shares, a 9.13% increase year-over-year.
  • Nexien Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 66.2M shares, a 6.19% increase from 2023.
  • Nexien Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 62.3M shares, a 7.73% increase from 2022.
  • Nexien Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 57.9M shares, a 4.44% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 70.5M +5.9M +9.13% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 66.2M +3.86M +6.19% Apr 1, 2024 Jun 30, 2024 10-K 2024-10-22
Q1 2024 66.4M +3.75M +5.98% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 65.1M +3.19M +5.16% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 64.6M +3.5M +5.73% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 62.3M +4.47M +7.73% Apr 1, 2023 Jun 30, 2023 10-K 2024-10-22
Q1 2023 62.6M +3.56M +6.02% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 61.9M +5.7M +10.1% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 61.1M +5.3M +9.51% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 57.9M Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 59.1M +3.85M +6.98% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-17
Q4 2021 56.2M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 55.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q1 2021 55.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.